Keyphrases
GATA2
100%
Germline Variants
100%
DDX41
100%
Runt-related Transcription Factor 1 (RUNX1)
100%
Mutational Landscape
100%
Secondary Haematological Malignancies
100%
Hematological Malignancies
60%
Clonal Hematopoiesis
50%
Leukemogenesis
30%
Malignancy
30%
Germ Cells
30%
Tet Methylcytosine Dioxygenase 2
20%
PHF6
20%
Clinical Trials
10%
Counseling
10%
Clinical Monitoring
10%
Potential Gains
10%
Gene-specific
10%
Paucity
10%
Surveillance Program
10%
Early Onset
10%
High Prevalence
10%
Medical Surveillance
10%
Genetic Drivers
10%
Clinical Trial Monitoring
10%
Preemptive Treatment
10%
International Cohort
10%
Somatic Variants
10%
Biochemistry, Genetics and Molecular Biology
Germline
100%
DDX41
100%
GATA2
100%
RUNX1
100%
Germ Cell
100%
Hematopoiesis
50%
PHF6
20%
Clinical Trial
10%
Genetics
10%
Prevalence
10%
Precursor
10%